Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 113.91M | 110.33M | 100.02M | 94.51M | 92.69M | 81.48M |
Gross Profit | 45.35M | 55.45M | 50.52M | 49.02M | 44.85M | 36.44M |
EBITDA | 18.20M | 15.60M | 10.20M | 17.53M | 13.73M | 6.54M |
Net Income | 9.81M | 8.72M | 3.92M | 10.96M | 7.50M | -6.12M |
Balance Sheet | ||||||
Total Assets | 107.16M | 103.94M | 107.91M | 104.29M | 90.14M | 68.58M |
Cash, Cash Equivalents and Short-Term Investments | 20.95M | 18.39M | 19.62M | 18.18M | 14.66M | 3.15M |
Total Debt | 10.40M | 8.25M | 9.66M | 11.50M | 13.23M | 10.53M |
Total Liabilities | 43.49M | 42.38M | 52.92M | 48.00M | 47.51M | 41.23M |
Stockholders Equity | 63.43M | 61.34M | 54.78M | 56.09M | 42.52M | 28.30M |
Cash Flow | ||||||
Free Cash Flow | 4.41M | 1.63M | 9.55M | 12.30M | 15.53M | 9.28M |
Operating Cash Flow | 4.41M | 2.66M | 10.42M | 12.85M | 16.88M | 14.27M |
Investing Cash Flow | 0.00 | 1.55M | -761.00K | -2.78M | -5.33M | -2.54M |
Financing Cash Flow | 0.00 | -5.27M | -8.18M | -6.63M | 16.00K | -12.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €47.68B | 5.05 | 5.52% | 7.06% | 1.62% | -38.38% | |
74 Outperform | €132.00M | 11.76 | 17.44% | 2.61% | 4.75% | -15.60% | |
70 Outperform | €48.20B | 24.87 | 19.07% | 1.51% | 14.88% | 13.32% | |
66 Neutral | $3.29B | 16.99 | 7.25% | 2.75% | 3.22% | -28.92% | |
63 Neutral | €13.61B | 22.11 | 4.37% | 3.10% | 0.10% | 27.83% | |
61 Neutral | €5.86B | 12.16 | -11.12% | 4.18% | 3.79% | -34.20% | |
56 Neutral | €37.50B | 97.61 | 2.02% | 5.35% | -0.77% | ― |